Synthetic RIG-I agonist-mediated cancer immunotherapy synergizes with MAP-Kinase inhibition against BRAF mutated melanoma [YUMM1.7]
Ontology highlight
ABSTRACT: Synthetic RIG-I agonist-mediated cancer immunotherapy synergizes with MAP-Kinase inhibition against BRAF mutated melanoma [YUMM1.7]
PROVIDER: PRJNA1119955 | ENA |
REPOSITORIES: ENA
ACCESS DATA